EURACTIV reports from the European Society of Cardiology 2015 congress, the largest and most influential cardiovascular event.
This year’s event in London turned towards the patient, with a focus on how to improve patient care by communicating significant advances in prevention, diagnosis and treatment of cardiovascular disease.
This Special Report is also available in French (lire la couverture ici), in German (hier finden Sie unsere Berichterstattung), in Italian (leggi lo speciale) and in Spanish (lea la cobertura aquí).
SPECIAL REPORT / Although cardiovascular diseases are still the number one killer in the world, they do not receive enough attention from policymakers due to many misconceptions, says Johanna Ralston.
SPECIAL REPORT / New medicines soon expected to hit the European market will allow patients to lower their levels of bad cholesterol more substantially than is currently possible, opening new avenues for tackling heart diseases.
SPECIAL REPORT / Under constant budgetary pressure, healthcare providers have to make tough decisions on a daily basis, on where to make savings. Cost effectiveness analysis will soon become part of health policymakers’ standard toolkit to ensure the best outcome, analysts say.
SPECIAL REPORT / Researchers have called for lowering the official recommended threshold for bad cholesterol, arguing new drugs now make it possible to go below the currently accepted limit.
SPECIAL REPORT / Europe’s leading cardiologists have advised policymakers to look into unexpected areas such as e-cigarettes and personalised medicine in their efforts to prevent cardiovascular diseases.